Hyperhomocysteinemia as a Risk Factor for Arterial and Venous Disease. A Review of Evidence and Relevance

• References

• 1 Mudd SH, Levy HL, Skovby F. 1995. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D. (eds) The metabolic and molecular basis of inherited disease. New York: McGraw-Hill: 1995. pp 1279-1327
• 2 Boers GHJ. Homocystinuria, a risk factor of premature vascular disease. Clinical Research Series. No 3. Dordrecht-Holland/Riverton- USA: Foris Publications; 1986
• 3 Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Audria G, Boers GHJ, Homberg IL, Cerone R, Fowler B, Gröbe H, Schmidt H, Schweitzer L. The natural history of homocystinuria due to cystathionine-β-synthase deficiency. Am J Hum Genet 1985; 37: 1-31
• 4 Boers GHJ, Smals AGH, Trijbels JMF, Fowler B, Bakkeren JAJM, Schoonderwaldt JC, Kleijer WJ, Kloppenborg PWC. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 313: 709-715
• 5 Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-1155
• 6 Kluijtmans LAJ, van de Heuvel LPWJ, Boers GHJ, Frosst P, Stevens EMB, van Oost BA, Den Heijer M, Trijbels JMF, Rosen R, Blom HJ. Molecular genetic analysis in mild hyperho-mocysteinemia: A common mutation in the methyl-enetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58: 35-41
• 7 Engbersen AMT, Franken DG, Boers GHJ, Stevens EMB, Trijbels FJM, Blom HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995; 56: 142-150
• 8 Sardharwalla IB, Fowler B, Robinson AJ, Komrower GM. Detection of heterozygotes for homocystinuria. Arch Dis Child 49 1974; 553-559
• 9 Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 57 1976; 211-215
• 10 Boers GHJ, Schoonderwaldt HC, Schulte PBM, Trijbels JMF, Smals AGH, Kloppenborg PWC. Heterozygosity for homocystinuria: a risk factor of occlusive cerebrovascular disease. Clin Genet 24 1983; 300-301
• 11 Boers GHJ. Hyperhomocysteinemia: a newly recognized risk factor for vascular disease. Neth J Med 45 1994; 34-41
• 12 Ueland PM, Refsum H, Brattström L. Plasma homocysteine and cardiovascular disease. In: Francis Jr RB. (eds) Atherosclerotic cardiovascular disease, hemostasis, and endothelial function. New York: Marcel Dekker: 1992. pp 183-236
• 13 Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274 1995; 1049-1057
• 14 Daly LE, Meleady R, Graham IM. Fasting or post methionine load homocysteine: which should be measured in relation to vascular risk. (Abstract) Irish J Med Sci. 1995: 164 suppl. 15,6
• 15 Graham IM, Daly LE, Refsum HM, Robinson K, Brattström LE, Ueland PM, Palma-Reis RJ, Boers GHJ, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997 (in press)
• 16 Bienvenu T, Ankri A, Chadefaux B, Kamoun P. Dosage de l’homocysteine plasmatique dans l’exploration des thromboses du sujet jeune. Presse Med 20 1991; 985-988
• 17 Brattström L, Tengbom L, Lagerstedt C, Israelsson B, Hultbeig B. Plasma homocysteine in venous thromboembolism. Haemostasis 1991; 21: 51-57
• 18 Rees MM, Rodgers GM. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 71 1993; 337-359
• 19 Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Munnucci PM. High prevalence of hyperhomocysteinemia in patients with juvenile venous thrombosis. Arterioscler Thromb 14 1994; 1080-1083
• 20 Den Heijer M, Koster T, Blom HJ, Bos GMJ, Briët E, Reitsma PH, Vandebroucke JP, Rosendaal FR. Hyperhomocysteinemia as a risk factor for deep vein thrombosis. N Eng J Med 334 1996; 759-762
• 21 Den Heijer M, Blom HJ, Gerrits WBJ, Rosendaal FR, Haak HL, Wijermans PW, Bos GMJ. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis. Lancet 345 1995; 882-885
• 22 Mandel H, Brenner B, Berant M, Rosenberg N, Lanir N, Jacobs C, Fowler B, Seligsohn U. Coexistence of heriditary homocystinuria and factor V Leiden, effect on thrombosis. N Eng J Med 334 1996; 763-768
• 23 D’Angelo A, Fermo I, d’Angelo SV. Thrombophilia, homocystinuria, and mutation of the factor V gene. (Letter) N Eng J Med 1996; 335: 289
• 24 Quéré I, Lamarti H, Chadefaux-Vekemans B. Thrombophilia, homocystinuria, and mutation of the factor V gene. (Letter) NEngJ Med 1996; 335: 289
• 25 Petri M, Roubenoff R, Dallal GE, Nadeau MR, Selhub J, Rosenberg IM. Events in systemic lupus erythematosus. Lancet 1996; 348: 1120-1124